image: The drug candidate FR induced differentiation in three types of uveal melanoma cells after three days of treatment. This material relates to a paper that appeared in the Sept. 5, 2018, issue of Science Translational Medicine, published by AAAS. The paper, by M.D. Onken at Washington University School of Medicine in St. Louis, MO; and colleagues was titled, " Targeting nucleotide exchange to inhibit constitutively active G protein alpha subunits in cancer cells." view more
Credit: M.D. Onken<i> et al., Science Signaling </i>(2018)